Stockreport

Arcus Biosciences Announces Final Safety Results From Phase 1 Trial for AB928 in Healthy Volunteers

Arcus Biosciences, Inc.  (RCUS) 
Last arcus biosciences, inc. earnings: 3/5 04:10 pm Check Earnings Report
PDF - AB928 was safe and well tolerated at all doses evaluated - - Safety and pharmacodynamic data from healthy volunteer trial support selection of [Read more]